Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Future therapies in hormone-refractory prostate cancer.
Smith MR, Nelson JB. Smith MR, et al. Among authors: nelson jb. Urology. 2005 May;65(5 Suppl):9-16; discussion 17. doi: 10.1016/j.urology.2005.03.043. Urology. 2005. PMID: 15885273 Review.
Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment.
Carroll PR, Benaron DA, Blackledge G, Coakley FV, D'Amico AV, Higano CS, Iversen P, Kattan M, Nanus DM, Nelson JB, Oh WK, Roach M 3rd, Sellers WR, Smith MR, McMann MC, Kantoff PW. Carroll PR, et al. Among authors: nelson jb. J Urol. 2003 Dec;170(6 Pt 2):S3-5. doi: 10.1097/01.ju.0000095101.18470.a0. J Urol. 2003. PMID: 14610403 Review. No abstract available.
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer.
Carducci MA, Saad F, Abrahamsson PA, Dearnaley DP, Schulman CC, North SA, Sleep DJ, Isaacson JD, Nelson JB; Atrasentan Phase III Study Group Institutions. Carducci MA, et al. Among authors: nelson jb. Cancer. 2007 Nov 1;110(9):1959-66. doi: 10.1002/cncr.22996. Cancer. 2007. PMID: 17886253 Free article. Clinical Trial.
Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment.
Carroll PR, Chan JM, D'Amico AV, Gelmann EP, Iversen P, Klotz L, Nelson JB, Nelson PS, Nelson WG, Oh WK, Rosen N, Rubin MA, Sandler H, Sellers WR, Smith MR, Xu J, McMann MC, Kantoff PW. Carroll PR, et al. Among authors: nelson jb, nelson wg, nelson ps. J Urol. 2004 Nov;172(5 Pt 2):S3-5. doi: 10.1097/01.ju.0000142276.19511.ac. J Urol. 2004. PMID: 15535434 Review. No abstract available.
A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer.
Yang Z, Wang D, Johnson JK, Pascal LE, Takubo K, Avula R, Chakka AB, Zhou J, Chen W, Zhong M, Song Q, Ding H, Wu Z, Chandran UR, Maskrey TS, Nelson JB, Wipf P, Wang Z. Yang Z, et al. Among authors: nelson jb. Mol Cancer Ther. 2020 Jan;19(1):75-88. doi: 10.1158/1535-7163.MCT-19-0489. Epub 2019 Sep 25. Mol Cancer Ther. 2020. PMID: 31554654 Free PMC article.
347 results